ACTIVE

Inspect

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result18,2 k €-69,5 %over 1 year
Gross margin93 k €-28,7 %over 1 year
Equity135,9 k €-4,9 %over 1 year

Identity

Source · BCE/KBO

Inspect is a Private limited company incorporated in 2016. Its main activity is: Management consultancy activities. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0645.950.417
Incorporation
14/01/2016
Legal form
Private limited company
Registered office
Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map
Contributed capital
18 800,00 €
Latest accounts
31/12/2025
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 10 filings

Trend over 10 financial years

20252024202320222021
Income statement
Gross margin93 k €130,6 k €66 k €19,1 k €14,2 k €
EBITDA35,9 k €84,6 k €65,4 k €18,6 k €13,7 k €
Operating result25,3 k €76,3 k €58 k €12,7 k €9,6 k €
Net result18,2 k €59,6 k €39,3 k €9,6 k €7,2 k €
Balance sheet
Equity135,9 k €143 k €83,4 k €47,6 k €28,5 k €
Total assets218 k €227,5 k €127,3 k €89,7 k €36,5 k €
Cash100,4 k €88,2 k €42,9 k €23,7 k €11,2 k €
Debts82,1 k €72 k €43,9 k €42,1 k €8 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Tim De Kock
DirectorManager2019 accountsended

Other companies at this address

Technologiepark-Zwijnaarde 82 9052 Gent
CompanyCBE no.
Amalus Therapeutics● Bankrupt
0803.929.268
APCOR R&M● Active
0600.952.909
Ardoyen● Active
0875.102.821
AVROXA● Active
0687.774.936
Benebiose● Active
0784.521.548
BioNeering● Active
0807.194.309
CONTREL EUROPE● Active
0426.204.637
CRODEON TECHNOLOGIES● Active
0642.754.761
Cryptobiotix● Active
0762.565.104
Gulliver Biomed● Active
0692.527.837
ImplicitMeasures.com● Bankrupt
0657.989.701
Inbiose● Active
0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active
0440.054.752
INNOVATIVE PHARMACEUTICS● Active
0883.574.582
INVIBES ADVERTISING● Active
0836.533.938
KYTOS● Active
0768.755.286
Lares Solutions● Active
1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active
0755.350.975
Microbial Resource Management Health● Active
0742.910.132
Microbial Resource Management Technologies● Active
0667.765.816

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date16/06/202620/06/202503/07/202421/06/202317/06/202218/06/2021
General meeting08/06/202607/06/202527/06/202407/06/202307/06/202207/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 10 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202508/06/202616/06/2026DutchPDF
Micro model31/12/202407/06/202520/06/2025DutchPDF
Micro model31/12/202327/06/202403/07/2024DutchPDF
Micro model31/12/202207/06/202321/06/2023DutchPDF
Micro model31/12/202107/06/202217/06/2022DutchPDF
Micro model31/12/202007/06/202118/06/2021DutchPDF
Micro model31/12/201908/06/202015/06/2020DutchPDF
Micro model31/12/201807/06/201925/06/2019DutchPDF
Micro model31/12/201707/06/201806/07/2018DutchPDF
Micro model31/12/201607/06/201730/06/2017DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Tim De Kock
DirectorManager2019 accountsended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates05/04/2023
    MAATSCHAPPELIJKE ZETEL, ONTSLAGEN, BENOEMINGEN,
    PDF
  • Registered office18/01/2016
    ~~Er blijkt uit een akte verleden voor meester Ilse De Brauwere, geassocieerd notaris, met zetel van
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings10 filings
Mandates
Tim De Kock
20162017201820192020202120222023202420252026
Inspect
Technologiepark-Zwijnaarde 82, 9052 Zwijnaarde
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Technologiepark-Zwijnaarde 82, 9052 ZwijnaardeCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00164875

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
InspectCurrent
accounts 2016 → 2025
Accounts 2025 · 2026-00164875

Events

  1. 2025
    Annual accounts 202518,2 k €↓
  2. 2024
    Annual accounts 202459,6 k €↑
  3. 2023
    Annual accounts 202339,3 k €↑
  4. 2022
    Annual accounts 20229,6 k €↑
  5. 2021
    Annual accounts 20217,2 k €↓
  6. 2020
    Annual accounts 202014,4 k €↑
  7. 2019
    Annual accounts 2019-4 k €↓
  8. 2018
    Annual accounts 20184,1 k €↓
  9. 2017
    Annual accounts 20174,2 k €↓
  10. 2016
    Annual accounts 20166,1 k €
  11. 14/01/2016
    IncorporationPrivate limited company